April 23, 2024

Global Action in Healthcare Network (GAIHN) Forum on Genomic Sequencing and Epidemiologic Surveillance in Healthcare Facilities

These recordings include presentations by GAIHN country teams and facilitated panel discussions. The videos share experiences and findings from SARS-CoV-2 variant surveillance activities across the GAIHN country networks, and discuss the role and utility of genomic sequencing in healthcare facility-based epidemiologic surveillance. The participating networks are located in Brazil, Jordan, Indonesia, and the Philippines.

DISCLAIMER: All findings and conclusions shared in this forum are those of the participants and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention or any participating entity.

Session

Country lead

      Topic

Video recording type

Public link

1

CDC

Introduction

Presentation English



Presentation Arabic



Presentation Bahasa Indonesia



Presentation Portuguese


https://healthsecuritypartners.instructuremedia.com/embed/56775011-3b25-47ca-81eb-e880ea6fcaac



https://healthsecuritypartners.instructuremedia.com/embed/33851a98-aa25-49e6-9616-f07cdb0f6bd6




https://healthsecuritypartners.instructuremedia.com/embed/a091c92a-d9b1-4d96-a838-e83618742098



https://healthsecuritypartners.instructuremedia.com/embed/cc15d99d-4397-4084-92a5-e4a3ca2d7c76

2

Brazil

Brazil Network SARS-CoV-2 Variant Characterization Summary

Presentation English



Presentation Arabic



Presentation Bahasa Indonesia



Presentation Portuguese



https://healthsecuritypartners.instructuremedia.com/embed/979850d4-2966-4a0e-91a2-1f8840ae09ae



https://healthsecuritypartners.instructuremedia.com/embed/dc63b6b9-ca0e-455c-bdd8-dd1be3b3ce9d




https://healthsecuritypartners.instructuremedia.com/embed/ba16ed27-db0d-4407-b2ab-e33987698170



https://healthsecuritypartners.instructuremedia.com/embed/c65ed1c6-15fb-4955-9ee8-ec6263a5c621


2

Brazil

Value and utility of healthcare-facility based genomic sequencing for generalized, national, or regional public health surveillance activities

Panel discussion English


Panel discussion Arabic



Panel discussion Bahasa Indonesia


Panel discussion Portuguese

https://healthsecuritypartners.instructuremedia.com/embed/f759425d-881d-4a57-88c3-37c9d7ff5a7e



https://healthsecuritypartners.instructuremedia.com/embed/ca136693-c12e-4cc8-a5bc-ef9ded4165b9




https://healthsecuritypartners.instructuremedia.com/embed/fc2d2cea-275f-4316-93db-1dff6e60a2d3




https://healthsecuritypartners.instructuremedia.com/embed/eae48b72-9251-4e1b-9b6e-0a4c1bcbadb1

3

The Philippines

Philippine Network SARS-CoV-2 Variant Characterization Summary

Presentation English


Presentation Arabic



Presentation Bahasa Indonesia


Presentation Portuguese

https://healthsecuritypartners.instructuremedia.com/embed/3be174d4-f7ad-4e6a-94e9-225804174361


https://healthsecuritypartners.instructuremedia.com/embed/2f84d159-a6b1-487c-9126-5aacc49c324c



https://healthsecuritypartners.instructuremedia.com/embed/e1584ebb-6c66-4a91-a6a0-76a32a286925



https://healthsecuritypartners.instructuremedia.com/embed/87ee5839-fabd-4ac3-afec-4422540f8a52

3

The Philippines

Value of facility-level variant characterization to inform facility-level response activities

Panel discussion English


Panel discussion Arabic



Panel discussion Bahasa Indonesia


Panel discussion Portuguese

https://healthsecuritypartners.instructuremedia.com/embed/904dbf3a-e4bc-4f02-ad68-15cddbf1f478



https://healthsecuritypartners.instructuremedia.com/embed/710119be-0994-45d3-9246-6a2ea8f8d081




https://healthsecuritypartners.instructuremedia.com/embed/07d08d01-91b1-4c2d-9d90-31f88edb0679




https://healthsecuritypartners.instructuremedia.com/embed/c2ad5060-ad98-4364-8928-7d8a0ff66bd1

4

Jordan

Jordan Network SARS-CoV-2 Variant Characterization Summary

Presentation English


Presentation Arabic



Presentation Bahasa Indonesia


Presentation Portuguese

https://healthsecuritypartners.instructuremedia.com/embed/673185a3-d759-4523-acbb-b4051b45cfc7


https://healthsecuritypartners.instructuremedia.com/embed/a3dcb897-0050-4451-8336-b503e3b8cd3c





https://healthsecuritypartners.instructuremedia.com/embed/4d877a2e-00fa-4fc7-9fdc-33ecf90b815c

4

Jordan

Value and applicability of facility-level genomic sequencing capacity to other emerging infections and public health emergency responses

Panel discussion English


Panel discussion Arabic



Panel discussion Bahasa Indonesia


Panel discussion Portuguese

https://healthsecuritypartners.instructuremedia.com/embed/3cd927db-9e9e-4134-8133-a5fc99c9efb6



https://healthsecuritypartners.instructuremedia.com/embed/58738511-10d2-4ced-b1b4-7e0b3f049542




https://healthsecuritypartners.instructuremedia.com/embed/a55ba5b8-a660-400e-808a-2fa26dabde12




https://healthsecuritypartners.instructuremedia.com/embed/ac3430fe-cf58-4437-9b7d-f9517da06fe7

5

Indonesia

Indonesia Network SARS-CoV-2 Variant Characterization Summary

Presentation English



Presentation Arabic


Presentation Bahasa Indonesia


Presentation Portuguese

https://healthsecuritypartners.instructuremedia.com/embed/1c9a0f55-7b51-49a6-94b7-8d868fd6d8ac



https://healthsecuritypartners.instructuremedia.com/embed/9dccb989-f1f5-4589-b16d-e17fb63994ab


https://healthsecuritypartners.instructuremedia.com/embed/50b99079-e8a2-45f3-9eec-46e996b3eac0 



https://healthsecuritypartners.instructuremedia.com/embed/529a2231-ea03-439c-8c84-6e8537ea9083

5

Indonesia

Challenges in establishing facility-level variant characterization and limitations in data interpretation and use

Panel discussion English



Panel discussion Arabic


Panel discussion Bahasa Indonesia


Panel discussion Portuguese

https://healthsecuritypartners.instructuremedia.com/embed/a76e7a9b-3c58-49ad-9115-6217326dc396




https://healthsecuritypartners.instructuremedia.com/embed/f505d8f5-3e5c-4869-bb6c-5cf824de5efa



https://healthsecuritypartners.instructuremedia.com/embed/0f853d01-506e-4404-b5ef-c6ae38b0ab20




https://healthsecuritypartners.instructuremedia.com/embed/a24602c0-0c67-45f4-9bdf-3595a37a3e2d